Cardiology
Service
Institute of Clinical and Experimental Medicine
Praga, República ChecaPublications in collaboration with researchers from Institute of Clinical and Experimental Medicine (14)
2024
-
Pregnancy in women with dilated cardiomyopathy genetic variants
Revista Espanola de Cardiologia
-
Redefining the molecular rejection states in 3230 heart transplant biopsies: Relationships to parenchymal injury and graft survival
American Journal of Transplantation, Vol. 24, Núm. 8, pp. 1414-1426
2022
-
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC
Cor et Vasa, Vol. 64, pp. 4-55
-
Cardiovascular disease and COVID-19, a deadly combination: A review about direct and indirect impact of a pandemic
World Journal of Clinical Cases, Vol. 10, Núm. 27, pp. 9556-9572
-
Correction to: Surgery and outcome of infective endocarditis in octogenarians: prospective data from the ESC EORP EURO-ENDO registry (Infection, (2022), 50, 5, (1191-1202), 10.1007/s15010-022-01792-0)
Infection
-
Natural History of MYH7-Related Dilated Cardiomyopathy
Journal of the American College of Cardiology, Vol. 80, Núm. 15, pp. 1447-1461
-
Surgery and outcome of infective endocarditis in octogenarians: prospective data from the ESC EORP EURO-ENDO registry
Infection, Vol. 50, Núm. 5, pp. 1191-1202
2021
-
Prevalence and clinical outcomes of dystrophin-associated dilated cardiomyopathy without severe skeletal myopathy
European Journal of Heart Failure, Vol. 23, Núm. 8, pp. 1276-1286
2020
-
Intramural Venous Ethanol Infusion for Refractory Ventricular Arrhythmias: Outcomes of a Multicenter Experience
JACC: Clinical Electrophysiology, Vol. 6, Núm. 11, pp. 1420-1431
-
Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use
Journal of cardiovascular pharmacology, Vol. 76, Núm. 1, pp. 4-22
-
Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use
Cardiac Failure Review, Vol. 6
-
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet, Vol. 396, Núm. 10253, pp. 759-769
2019
-
2019 EACTS Expert Consensus on long-term mechanical circulatory support
European Journal of Cardio-thoracic Surgery, Vol. 56, Núm. 2, pp. 230-270
-
The ESC-EORP EURO-ENDO (European Infective Endocarditis) registry
European Heart Journal - Quality of Care and Clinical Outcomes, Vol. 5, Núm. 3, pp. 202-207